Selection for beta 2-microglobulin mutation in mismatch repair-defective colorectal carcinomas.
Novel peptide antigens complexed with human leukocyte antigen (HLA) and beta 2-microglobulin (beta 2M) molecules are presented at the cell surface to cytotoxic T lymphocytes (CTLs), provoking lysis of the antigen-presenting cell [1]. In tumor cells, genetically altered or abnormally expressed protei...
Principais autores: | Bicknell, D, Kaklamanis, L, Hampson, R, Bodmer, W, Karran, P |
---|---|
Formato: | Journal article |
Idioma: | English |
Publicado em: |
1996
|
Registros relacionados
-
Beta 2-microglobulin gene mutations: a study of established colorectal cell lines and fresh tumors.
por: Bicknell, D, et al.
Publicado em: (1994) -
DNA mismatch repair in lymphoblastoid cells from hereditary non-polyposis colorectal cancer (HNPCC) patients is normal under conditions of rapid cell division and increased mutational load.
por: Tomlinson, I, et al.
Publicado em: (1997) -
Loss of HLA class-I alleles, heavy chains and beta 2-microglobulin in colorectal cancer.
por: Kaklamanis, L, et al.
Publicado em: (1992) -
Defects in mismatch repair occur after APC mutations in the pathogenesis of sporadic colorectal tumours.
por: Homfray, T, et al.
Publicado em: (1998) -
Immune surveillance in colorectal carcinoma.
por: Branch, P, et al.
Publicado em: (1995)